Stability studies of ionised and non-ionised 3,4-diaminopyridine: Hypothesis of degradation pathways and chemical structure of degradation products

3,4-Diaminopyridine in the Treatment of Lambert–Eaton Myasthenic Syndrome

Kathleen M. McEvoy, Anthony J. Windebank, Jasper R. Daube et al. · New England Journal of Medicine · 1989 · 306 citations

Medicine, Neurology, Pharmacotherapy +12

Response of the Lambert‐Eaton myasthenic syndrome to treatment of associated small‐cell lung carcinoma

Colin Chalk, N.M.F. Murray, John Newsom–Davis et al. · Neurology · 1990 · 216 citations

Medicine, Oncology, Neoplasia +12

Ring Nitrogen Oxidation of Amino Substituted Nitrogen Heterocycles with m-Chloroperbenzoic Acid

Leslie W. Deady · Synthetic Communications · 1977 · 25 citations

Natural Sciences, Chemistry, Medicinal Chemistry +13

Lambert-Eaton sera reduce low-voltage and high-voltage activated Ca2+ currents in murine dorsal root ganglion neurons.

Kelly García, Michelle Mynlieff, Donald B. Sanders et al. · Proceedings of the National Academy of Sciences · 1996 · 20 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Effect of 3,4-diaminopyridine on the time course of decay of compound muscle action potential augmentation in the Lambert-Eaton myasthenic syndrome

Paul Maddison, John Newsom–Davis, Kerry Mills · Muscle & Nerve · 1998 · 14 citations · Full text

Medicine, Neurology, Physiology +15